文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

衰弱与院内心脏骤停后的结局及资源利用

Frailty and associated outcomes and resource utilization following in-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2019-11-27
一句话结论院内心脏骤停患者中,衰弱(CFS≥5)与院内死亡和出院转长期护理的 odds 升高及 ROSC 的 odds 降低相关,且每存活者费用更高。

该研究为两所医院前瞻性登记 registry 的回顾性分析(2013-2016),纳入 477 例在病房发生院内心脏骤停的成人患者,以 Clinical Frailty Scale 评分≥5 定义衰弱(124 例,26.0%)。衰弱与院内死亡 adjusted OR 2.91(95%CI 2.37-3.48)和出院转长期护理 adjusted OR 1.94(95%CI 1.57-2.32)的 odds 升高相关,与 ROSC 的 odds 降低相关(aOR 0.63,95%CI 0.41-0.93)。两组平均总费用无差异(衰弱组 $50,799 vs 非衰弱组 $45,849),但衰弱组每存活者费用更高($947,546 vs $161,550)。

要点

  • 在病房发生 IHCA 的成人中,CFS≥5 定义的衰弱者院内死亡 adjusted OR 2.91(95%CI 2.37-3.48)。
  • 衰弱者出院转长期护理的 adjusted OR 1.94(95%CI 1.57-2.32),高于非衰弱者。
  • 衰弱者 IHCA 后 ROSC 的 adjusted OR 0.63(95%CI 0.41-0.93),低于非衰弱者。
  • 衰弱与非衰弱者平均总费用无差异($50,799 vs $45,849),但衰弱者每存活者费用更高($947,546 vs $161,550)。

适用人群与场景

  • 两所医院病房发生院内心脏骤停的连续住院成人患者(2013-2016 年登记)。

诊断标准与关键阈值

  • 衰弱定义:Clinical Frailty Scale(CFS)评分≥5,评分基于经验证的医学审查标准。

研究设计与关键结果

  • 研究类型:前瞻性收集 registry 的回顾性分析,两所医院,纳入 477 例病房 IHCA 成人患者,其中 124 例(26.0%)存在衰弱。
  • 主要终点:衰弱者院内死亡 adjusted OR 2.91(95%CI 2.37-3.48)。
  • 关键次要终点:衰弱者出院转长期护理 adjusted OR 1.94(95%CI 1.57-2.32);ROSC adjusted OR 0.63(95%CI 0.41-0.93)。
  • 费用:衰弱组与非衰弱组平均总费用无差异($50,799 vs $45,849);衰弱组每存活者费用更高($947,546 vs $161,550)。

证据类型、等级与局限

  • 证据类型:回顾性分析(基于前瞻性收集的两所医院 registry)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,发生 IHCA 的衰弱个体更可能院内死亡或出院转长期护理,且更少达到 ROSC;存在衰弱时 IHCA 每存活者医院费用增加。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In-hospital cardiac arrest (IHCA) is common and associated with high mortality. Frailty is increasingly recognized as a predictor of worse prognosis among critically ill patients, but its association with outcomes and resource utilization following IHCA is unknown.

METHODS: We performed a retrospective analysis (2013-2016) of a prospectively collected registry from two hospitals of consecutive hospitalized adult patients with IHCA occurring on the hospital wards. We defined frailty using the Clinical Frailty Scale (CFS) score ≥5. CFS scores were based on validated medical review criteria. The primary outcome is hospital mortality. Secondary outcomes include return of spontaneous circulation (ROSC), discharge to long-term care, and hospital costs. We used multivariable logistic regression to adjust for known confounders.

RESULTS: We included 477 patients, and 124 (26.0%) had frailty. Frailty was associated with increased odds of hospital death (adjusted odds ratio [aOR]: 2.91 [95% confidence interval [CI]: 2.37-3.48) and discharge to long-term care (aOR 1.94 [95% CI: 1.57-2.32]). Compared with patients without frailty, patients with frailty had decreased odds of ROSC following IHCA (aOR 0.63 [95% CI: 0.41-0.93]). No difference in mean total costs was demonstrated between patients with and without frailty ($50,799 vs. $45,849). Frail patients did have higher cost-per-survivor ($947,546 vs. $161,550).

CONCLUSIONS: Frail individuals who experience an IHCA are more likely to die in hospital or be discharged to long-term care, and less likely to achieve ROSC in comparison with individuals who are not frail. The hospital costs per-survivor of IHCA are increased when frailty is present.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Fernando SM, McIsaac DI, Rochwerg B, et al. Frailty and associated outcomes and resource utilization following in-hospital cardiac arrest. Resuscitation. 2019. PMID: 31785373. doi:10.1016/j.resuscitation.2019.11.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。